Europe • Frankfurt Stock Exchange • FRA:SYK • US8636671013
The current stock price of SYK.DE is 309.2 EUR. In the past month the price increased by 0.78%.
ChartMill assigns a technical rating of 3 / 10 to SYK.DE.
ChartMill assigns a fundamental rating of 6 / 10 to SYK.DE. While SYK.DE has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months SYK.DE reported a non-GAAP Earnings per Share(EPS) of 11.45. The EPS increased by 11.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.92% | ||
| ROA | 6.78% | ||
| ROE | 14.48% | ||
| Debt/Equity | 0.66 |
36 analysts have analysed SYK.DE and the average price target is 366.63 EUR. This implies a price increase of 18.57% is expected in the next year compared to the current price of 309.2.
For the next year, analysts expect an EPS growth of 10.94% and a revenue growth 8.99% for SYK.DE
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 16.14 | 107.599B | ||
| SHL | SIEMENS HEALTHINEERS AG | 17.04 | 45.233B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 17.81 | 25.662B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 17.47 | 25.595B | ||
| BIM | BIOMERIEUX | 18.56 | 11.002B | ||
| DIA | DIASORIN SPA | 18.15 | 4.143B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 18.47 | 3.609B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.28 | 2.426B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.89 | 1.634B | ||
| DRW8 | DRAEGERWERK AG | 9.45 | 1.294B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan. The firm offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The firm also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
STRYKER CORP
1941 Stryker Way
Portage MICHIGAN US
Employees: 53000
Phone: 12693852600
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan. The firm offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The firm also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
The current stock price of SYK.DE is 309.2 EUR. The price increased by 3.86% in the last trading session.
STRYKER CORP (SYK.DE) has a dividend yield of 0.97%. The yearly dividend amount is currently 2.85.
SYK.DE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SYK.DE.
The Revenue of STRYKER CORP (SYK.DE) is expected to grow by 8.99% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
STRYKER CORP (SYK.DE) has a market capitalization of 118.24B EUR. This makes SYK.DE a Large Cap stock.